Consensus on the secondary prevention of primary liver cancer

作者：Yuemin Nan, Xiaoyuan Xu, Yanhang Gao, Rongqi Wang, Wengang Li, Ming Yang, Lingdi Liu, Zhongping Duan, Jidong Jia, Lai Wei, Hui Zhuang, Huiguo Ding, Zhongping Duan, Jian-Gao Fan, Qinmao Fang, Yanhang Gao, Peng Hu, Jidong Jia, Wengang Li, Jingfeng Liu, Junqi Niu, Yuemin Nan, Jia Shang, Rongqi Wang, Lai Wei, Yanyan Yu, Yuguo Zhang, Suxian Zhao, Jian Zhou, Weifeng Zhao, Xiaoyuan Xu, Chuanmiao Xie, Wen Xie, Ming Yang, Hui Zhuang · 发表于：Hepatology International · 年份：2021 · DOI：10.1007/s12072-021-10259-7 · 被引用次数：17 · 研究领域：Liver Disease Diagnosis and Treatment、Hepatitis B Virus Studies、Hepatocellular Carcinoma Treatment and Prognosis

To standardize the effective prevention, surveillance, and diagnosis of primary liver cancer, the Chinese Society of Hepatology, Chinese Medical Association, invited clinical experts and methodologists to develop the Consensus on the Secondary Prevention of Primary Liver Cancer, which was based on the clinical and scientific advances on hepatocellular carcinoma. The purpose is to provide a current basis for the prevention, surveillance, and early diagnosis of primary liver cancer in patients with chronic liver diseases.